Skip to main content

Advertisement

SpringerLink
Log in

Efficacy of High-Dose Intra-dermal Hepatitis B Virus Vaccine in Previous Vaccination Non-responders with Chronic Liver Disease

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Hepatitis B virus (HBV) vaccination is essential in chronic liver disease (CLD), because it can help prevent acute-on-chronic disease, which has potentially fatal complications. Unfortunately, this group has a significant proportion of HBV vaccination non-responders. A variety of intra-muscular (IM) vaccination methods have been used in an attempt to remedy this poor-response, but with limited success.

Aims

Herein is reported the safety and efficacy of high-dose intra-dermal (ID) HBV vaccination in CLD individuals who had failed previous IM standard and boost-dosing regimens.

Methods

Forty-eight CLD individuals, known HBcAb negative, who had failed both a three-dose schedule of 40 μg IM vaccination, and boost dosing of either 40 or 80 μg IM, were identified, of which 42 completed the vaccination course. Each received a 40 μg ID total dose (20 μg per arm) during their clinic visits until a response was documented or a maximum of three doses had been administered. HBsAb titer ≥10 mIU/ml was regarded as an immunologic response; the intention was to achieve an optimum response of ≥100 mIU/ml.

Results

Twenty-nine of forty-two (69%) individuals had an immunologic response, with 15 (51%) of the responders having the optimum response. No changes in serologic data occurred. No serious dermatologic reactions were observed. No differences between those who responded and those who did not were observed with regard to the presence of cirrhosis, diabetes mellitus, or chronic kidney disease.

Conclusions

High-dose ID HBV vaccination of previous CLD non-responders to the standard IM regimen with boost dosing is both safe and efficacious, and should be considered for all such groups.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev. 2006;28:112–125.

    Article  PubMed  Google Scholar 

  2. World Health Organization. Hepatitis B. (Fact sheet no. 204). Geneva, Switzerland: World Health Organization, 2000. http://www.who.int/mediacentre/factsheets/fs204/en/.

  3. Zanetti AR, Van Damme P, Shouval D, Vaccine. The global impact of vaccination against hepatitis B: a historical overview. Vaccine. 2008;26:6266–6273.

    Article  PubMed  Google Scholar 

  4. Wiedmann M, Liebert UG, Oesen U, et al. Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C. Hepatology. 2000;31:230–234.

    Article  PubMed  CAS  Google Scholar 

  5. Aziz A, Aziz S, Li DS, et al. Efficacy of repeated high-dose hepatitis B vaccine (80 μg) in patients with chronic liver disease. J Viral Hepat. 2006;13:217–221.

    Article  PubMed  CAS  Google Scholar 

  6. Keeffe EB. Acute hepatitis A and B in patients with chronic liver disease: prevention through vaccination. Am J Med. 2005;118:21S–27S.

    Article  PubMed  Google Scholar 

  7. Sangaré L, Manhart L, Zehrung D, Wang CC. Intradermal hepatitis B vaccination: a systematic review and meta-analysis. Vaccine. 2009;27:1777–1786.

    Article  PubMed  Google Scholar 

  8. Kallinowski B, Benz C, Buchholz L, Stremmel W. Accelerated schedule of hepatitis B vaccination in liver transplant candidates. Transplant Proc. 1998;30:797–799.

    Article  PubMed  CAS  Google Scholar 

  9. Rosman AS, Basu P, Galvin K, Lieber CS. Efficacy of a high and accelerated dose of hepatitis B vaccine in alcoholic patients: a randomized clinical trial. Am J Med. 1997;103:217–222.

    Article  PubMed  CAS  Google Scholar 

  10. Fabrizi F, Dixit V, Messa P, Martin P. Intradermal vs intramuscular vaccine against hepatitis B infection in dialysis patients: a meta-analysis of randomized trials. J Viral Hepat. 2010;31:1–8.

    Google Scholar 

  11. Arbizu EA, Marugán RB, Grijalba JY, Serrano PL, Grande LG, Del Campo Terrón S. Intramuscular versus intradermal administration of anti-hepatitis B vaccine in non-cirrhotic hepatitis C patients. Vaccine. 2003;21:2747–2750.

    Article  PubMed  CAS  Google Scholar 

  12. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol. 2005;34:1329–1339.

    Article  PubMed  Google Scholar 

  13. Arguedas MR, McGuire BM, Fallon MB. Implementation of vaccination in patients with cirrhosis. Dig Dis Sci. 2002;47:384–387.

    Article  PubMed  Google Scholar 

  14. Poland GA. Evaluating existing recommendations for hepatitis A and B vaccination. Am J Med. 2005;118:16S–20S.

    Article  PubMed  Google Scholar 

  15. Kramer JR, Hachem CY, Kanwal F, Mei M, El-Serag HB. Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection. Hepatology. 2011;53:42–52.

    Article  PubMed  Google Scholar 

  16. Wörns MA, Teufel A, Kanzler S, et al. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases. Am J Gastroenterol. 2008;103:138–146.

    Article  PubMed  Google Scholar 

  17. Engler SH, Sauer PW, Golling M, et al. Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates. Eur J Gastroenterol Hepatol. 2001;13:363–367.

    Article  PubMed  CAS  Google Scholar 

  18. Castells L, Esteban R. Hepatitis B vaccination in liver transplant candidates. Eur J Gastroenterol Hepatol. 2001;13:359–361.

    Article  PubMed  CAS  Google Scholar 

  19. Niiya T, Akbar SM, Yoshida O, et al. Impaired dendritic cell function resulting from chronic undernutrition disrupts the antigen-specific immune response in mice. J Nutr. 2007;137:671–675.

    PubMed  CAS  Google Scholar 

  20. Ghebrehewet S, Baxter D, Falconer M, Paver K. Intradermal recombinant hepatitis B vaccination (IDRV) for non-responsive healthcare workers (HCWs). Hum Vaccin. 2008;4:280–285.

    Article  PubMed  CAS  Google Scholar 

  21. Peces R, de la Torre M, Alcázar R, Urra JM. Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in hemodialysis patients. Am J Kidney Dis. 1997;29:239–245.

    Article  PubMed  CAS  Google Scholar 

  22. CDC. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR. 2001;50:1–43.

    Google Scholar 

  23. Belshe RB, Newman FK, Cannon J, et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med. 2004;351:2286–2294.

    Article  PubMed  CAS  Google Scholar 

  24. Nossal GJ. Host immunobiology and vaccine development. Lancet. 1997;350:1316–1319.

    Article  PubMed  CAS  Google Scholar 

  25. Sabchareon A, Chantavanich P, Pasuralertsakul S, et al. Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine. Pediatr Infect Dis J. 1998;17:1001–1007.

    Article  PubMed  CAS  Google Scholar 

  26. Chutivongse S, Wilde H, Supich C, Baer GM, Fishbein DB. Postexposure prophylaxis for rabies with antiserum and intradermal vaccination. Lancet. 1990;335:896–898.

    Article  PubMed  CAS  Google Scholar 

  27. Phanuphak P, Khawplod P, Sirivichayakul S, Siriprasomsub W, Ubol S, Thaweepathomwat M. Humoral and cell-mediated immune responses to various economical regimens of purified Vero cell rabies vaccine. Asian Pac J Allergy Immunol. 1987;5:33–37.

    PubMed  CAS  Google Scholar 

  28. Sangfelt P, Uhnoo I, Reichard O, Weiland O. A low-dose intradermal hepatitis B vaccine programme in health-care workers and students is highly effective and cost saving: a retrospective follow-up survey in the clinical setting. Scand J Gastroenterol. 2008;43:465–472.

    Article  PubMed  Google Scholar 

  29. McDermott AB, Cohen SBA, Zuckerman JN, Madrigal JA. Human leukocyte antigens influence the immune response to a pre-S/S hepatitis vaccine. Vaccine. 1999;17:330–339.

    Article  PubMed  CAS  Google Scholar 

  30. Caillat-Zucman S, Gimenez JJ, Wambergue F, et al. Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen. Kidney Int. 1998;53:1626–1630.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Department of Medicine, OSF St. Francis Medical Center, 2805N. Knoxville Avenue, Suite 209, Peoria, IL, 61604, USA

    S. Dhillon

  2. Division of Digestive Diseases, Rush University Medical Center, Chicago, IL, USA

    C. Moore & D. H. Van Thiel

  3. Division of Gastroenterology, Nutrition and Hepatology, Loyola University Medical Center, Chicago, IL, USA

    L. Murphy

  4. Premier Medical Associates, Fremont, CA, USA

    A. Kakar, A. Dosanjh & A. Beesla

  5. Mankato, MN, USA

    S. D. Li

  6. Hoffman Estates, IL, USA

    A. Aziz

Authors
  1. S. Dhillon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Moore
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. D. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Aziz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Kakar
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Dosanjh
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. Beesla
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. L. Murphy
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. D. H. Van Thiel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Dhillon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dhillon, S., Moore, C., Li, S.D. et al. Efficacy of High-Dose Intra-dermal Hepatitis B Virus Vaccine in Previous Vaccination Non-responders with Chronic Liver Disease. Dig Dis Sci 57, 215–220 (2012). https://doi.org/10.1007/s10620-011-1996-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-011-1996-0

Keywords

Search

Navigation